How can sequential therapy be used in castration-resistant prostate cancer?
Gerald Mickisch, MD, from the Bremen Center of Operative Urology, Bremen, Germany, discusses how sequential therapy can be used in the treatment of castration-resistant prostate cancer at the European...
Author: VJOncology
Added: 05/09/2017 (Source: Oncology Tube)
Source: Oncology Tube - May 9, 2017 Category: Cancer & Oncology Source Type: podcasts
ARASENS: Will combining different treatments improve prostate cancer survival?
Bertrand Tombal, MD, PhD, Catholic University of Leuven, Leuven, Belgium, discusses the ARASENS trial for prostate cancer at the European Association of Urology (EAU) conference 2017 in London, UK. He...
Author: VJOncology
Added: 05/09/2017 (Source: Oncology Tube)
Source: Oncology Tube - May 9, 2017 Category: Cancer & Oncology Source Type: podcasts
Is it possible to destroy the cancer while preserving the prostate?
Mark Emberton, MD, FRCS Urol, from University College London Hospitals NHS Foundation Trust, London, UK, discusses the potential of intraprostatic PRX302 injection for prostate cancer at the European ...
Author: VJOncology
Added: 05/09/2017 (Source: Oncology Tube)
Source: Oncology Tube - May 9, 2017 Category: Cancer & Oncology Source Type: podcasts
Robert Dreicer, MD, MS, FACP, FASCO - Need-to-Know Guidance for Navigating the Complex and Expanding Treatment Landscape in Prostate Cancer
Need-to-Know Guidance for Navigating the Complex and Expanding Treatment Landscape in Prostate Cancer (Source: PeerView CME/CE Audio Podcast - Oncology)
Source: PeerView CME/CE Audio Podcast - Oncology - May 8, 2017 Category: Cancer & Oncology Authors: PVI, PeerView Institute for Medical Education Tags: Science, Medicine Source Type: podcasts
Identifying Novel Metastasis Suppressor Genes in Prostate Cancer
Henry Withers of Roswell Park Cancer Institute, Department of Genetics gives an overview of his presentation, Characterization of an off-target RNAi genomic screen hit identifies GPRC6A as a novel sup...
Author: aacr2017
Added: 04/28/2017 (Source: Oncology Tube)
Source: Oncology Tube - April 28, 2017 Category: Cancer & Oncology Source Type: podcasts
Abstract Overview: Resistance to Anti-Androgen Therapy in Patients with Prostate Cancer
David Goodrich, PhD of Roswell Park Cancer Institute, Department of Pharmacology and Therapeutics gives an overview of his abstract, Rb1 suppresses prostate cancer metastasis and lineage plasticity un...
Author: aacr2017
Added: 04/27/2017 (Source: Oncology Tube)
Source: Oncology Tube - April 27, 2017 Category: Cancer & Oncology Source Type: podcasts
& quot;Hallmarks of Cancer & quot;: Treatment Trends for 2017
David Goodrich, PhD of Roswell Park Cancer Institute, Department of Pharmacology and Therapeutics discusses the treatment trends for prostate cancer in 2017 and gives an overview of an AACR session, w...
Author: aacr2017
Added: 04/27/2017 (Source: Oncology Tube)
Source: Oncology Tube - April 27, 2017 Category: Cancer & Oncology Source Type: podcasts
Clinical implications of CTCs in prostate cancer are they the best thing to measure?
Susanne Osanto, MD, PhD, from the Leiden University Medical Center, Leiden, Netherlands, discusses the clinical implications of circulating tumor cell (CTC) analysis in prostate cancer at the European...
Author: VJOncology
Added: 04/19/2017 (Source: Oncology Tube)
Source: Oncology Tube - April 19, 2017 Category: Cancer & Oncology Source Type: podcasts
How can germline mutations distinguish risk for lethal and indolent prostate cancer?
Rong Na, MD, from the Huashan Hospital, Fudan University, Shanghai, China discusses germline mutations in prostate cancer at the European Association of Urology (EAU) conference 2017 in London, UK. He...
Author: VJOncology
Added: 04/19/2017 (Source: Oncology Tube)
Source: Oncology Tube - April 19, 2017 Category: Cancer & Oncology Source Type: podcasts
USPSTF Casts Net Wider for PSA Screening; Education Is Key
Dr Chodak discusses proposed USPSTF prostate cancer screening guidelines and offers much needed education for patients on the pros and cons of screening. (Source: Medscape Urology Podcast)
Source: Medscape Urology Podcast - April 17, 2017 Category: Urology & Nephrology Authors: Medscape Source Type: podcasts
Prostate Cancer Screening Is Back in the News: What Now?
In new draft recommendations, the USPSTF proposes a reversal of their 2012 position on prostate cancer screening. (Source: Medscape Family Medicine Podcast)
Source: Medscape Family Medicine Podcast - April 17, 2017 Category: Primary Care Authors: Medscape Source Type: podcasts
PodMed – Week of April 17, 2017http://podcasts.hopkinsmedicine.org/2017/04/14/podmed-week-of-april-17-2017/
This week’s topics include deaths relative to diabetes, increases in both type 1 and type 2 diabetes among US youth, the benefits of spinal manipulation for low back pain, and draft recommendations regarding prostate cancer screening. Program notes: 0:40 Prostate cancer screening 1:38 Clinicians should inform on risks and benefits 2:40 Outcomes for 1000 men […] (Source: Johns Hopkins Medicine Weekly Health News)
Source: Johns Hopkins Medicine Weekly Health News - April 14, 2017 Category: Consumer Health News Authors: Elizabeth Tracey Johns Hopkins Medicine Tags: All Podcasts Breast Health Cancer Diabetes Pain And Pain Relief PodMed Prostate Health Source Type: podcasts
Disturbing Pattern of Recurrence in Men Post Radical Prostatectomy
Dr Gerald Chodak discusses the clinical implications of new data on recurrence patterns in prostate cancer patients following radical prostatectomy. (Source: Medscape Urology Podcast)
Source: Medscape Urology Podcast - April 12, 2017 Category: Urology & Nephrology Authors: Medscape Source Type: podcasts
